Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Suarez

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Transplantation and Cellular Therapy|June 13, 2024
Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in SpainMi Kwon, Ignacio Gómez-Centurión, Gillen Oarbeascoa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline UpdateBryan J Schneider, Jarushka Naidoo, Bianca D Santomasso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO GuidelineBianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, et al.
Arthritis Care & Research|April 5, 2012
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisJasvinder A Singh, Daniel E Furst, Aseem Bharat, et al.
The Journal of Rheumatology|October 6, 2005
Minimal disease activity for rheumatoid arthritis: a preliminary definitionGeorge A Wells, Maarten Boers, Beverley Shea, et al.
The Journal of Infectious Diseases|July 13, 2023
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell TransplantationJose Luis Piñana, Gloria Tridello, Aliénor Xhaard, et al.
Experimental Hematology & Oncology|April 26, 2025
Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD studyInes Zugasti, Monica Lopez-Guerra, Sandra Castaño-Díez, et al.
F1000Research|June 3, 2024
Systems Biology in ELIXIR: modelling in the spotlightVitor Martins Dos Santos, Mihail Anton, Barbara Szomolay, et al.
Microbiology Resource Announcements|June 10, 2025
Complete mitochondrial genome of the psammophilic fungus <i>Mallocybe</i> sp. (Inocybaceae, Basidiomycota) from CambodiaAmal F Alsaqaf, Ana C Avila Armenta, Lupita Avila, et al.
BMC Pregnancy and Childbirth|April 2, 2021
The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysisOscar Martinez-Perez, Pilar Prats Rodriguez, Marta Muner Hernandez, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Transplantation and Cellular Therapy|June 13, 2024
Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in SpainMi Kwon, Ignacio Gómez-Centurión, Gillen Oarbeascoa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline UpdateBryan J Schneider, Jarushka Naidoo, Bianca D Santomasso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO GuidelineBianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, et al.
Arthritis Care & Research|April 5, 2012
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisJasvinder A Singh, Daniel E Furst, Aseem Bharat, et al.
The Journal of Rheumatology|October 6, 2005
Minimal disease activity for rheumatoid arthritis: a preliminary definitionGeorge A Wells, Maarten Boers, Beverley Shea, et al.
The Journal of Infectious Diseases|July 13, 2023
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell TransplantationJose Luis Piñana, Gloria Tridello, Aliénor Xhaard, et al.
Experimental Hematology & Oncology|April 26, 2025
Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD studyInes Zugasti, Monica Lopez-Guerra, Sandra Castaño-Díez, et al.
F1000Research|June 3, 2024
Systems Biology in ELIXIR: modelling in the spotlightVitor Martins Dos Santos, Mihail Anton, Barbara Szomolay, et al.
Microbiology Resource Announcements|June 10, 2025
Complete mitochondrial genome of the psammophilic fungus <i>Mallocybe</i> sp. (Inocybaceae, Basidiomycota) from CambodiaAmal F Alsaqaf, Ana C Avila Armenta, Lupita Avila, et al.
BMC Pregnancy and Childbirth|April 2, 2021
The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysisOscar Martinez-Perez, Pilar Prats Rodriguez, Marta Muner Hernandez, et al.
Pageof 17